| # | Drug | Count |
|---|---|---|
| 0 | ALTEPLASE | 76 |
| 1 | ASPIRIN | 46 |
| 2 | ASPIRIN 325 MG | 44 |
| 3 | ASPIRIN 81 MG | 44 |
| 4 | DABIGATRAN ETEXILATE MESYLATE | 38 |
| 5 | RIVAROXABAN | 37 |
| 6 | DABIGATRAN ETEXILATE | 34 |
| 7 | CLOPIDOGREL | 32 |
| 8 | CLOPIDOGREL BISULFATE | 27 |
| 9 | FUROSEMIDE | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITROFURANTION | 1 | 0.0833 |
| 1 | EDARAVONE | 13 | 0.0081 |
| 2 | ALTEPLASE | 76 | 0.0051 |
| 3 | TENECTEPLASE | 7 | 0.0044 |
| 4 | ANDEXANET ALFA | 3 | 0.0042 |
| 5 | ERGOTAMINE TARTRATE AND CAFFEINE | 1 | 0.0037 |
| 6 | ARGATROBAN | 5 | 0.0033 |
| 7 | ANIDULAFUNGIN | 5 | 0.0031 |
| 8 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 9 | IDARUCIZUMAB | 3 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 57 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 57 |
| 2 | Factor Xa Inhibitor [EPC] | 55 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 48 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 27 |
| 5 | Loop Diuretic [EPC] | 25 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 19 |
| 8 | Proton Pump Inhibitor [EPC] | 19 |
| 9 | Calcium Channel Blocker [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 1 | Adrenal Steroid Synthesis Inhibitor [EPC] | 2 | 0.0020 |
| 2 | Anti-coagulant [EPC] | 5 | 0.0013 |
| 3 | Echinocandin Antifungal [EPC] | 7 | 0.0009 |
| 4 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 6 | Pyrethroid [EPC] | 1 | 0.0006 |
| 7 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 8 | Gonadotropin [EPC] | 1 | 0.0005 |
| 9 | Osmotic Diuretic [EPC] | 2 | 0.0004 |